The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
- Supplementary File 1:
PDF-Document (PDF, 465 KiB)
Asperti, M.; Cantamessa, L.; Ghidinelli, S.; Gryzik, M.; Denardo, A.; Giacomini, A.; Longhi, G.; Fanzani, A.; Arosio, P.; Poli, M. The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells. Pharmaceuticals 2019, 12, 129. https://doi.org/10.3390/ph12030129
Asperti M, Cantamessa L, Ghidinelli S, Gryzik M, Denardo A, Giacomini A, Longhi G, Fanzani A, Arosio P, Poli M. The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells. Pharmaceuticals. 2019; 12(3):129. https://doi.org/10.3390/ph12030129
Chicago/Turabian StyleAsperti, Michela; Cantamessa, Luca; Ghidinelli, Simone; Gryzik, Magdalena; Denardo, Andrea; Giacomini, Arianna; Longhi, Giovanna; Fanzani, Alessandro; Arosio, Paolo; Poli, Maura. 2019. "The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells" Pharmaceuticals 12, no. 3: 129. https://doi.org/10.3390/ph12030129